中风与神经疾病杂志2024，Vol.41Issue(8)：675-679,5.DOI:10.19845/j.cnki.zfysjjbzz.2024.0130
阻塞性睡眠呼吸暂停低通气综合征与阿尔茨海默病生物标志物研究进展
Advances in biomarkers of obstructive sleep apnea hypopnea syndrome and Alzheimer disease
葛键炜 1罗本燕1
作者信息
- 1. 浙江大学医学院附属第一医院,浙江 杭州 310000
- 折叠
摘要
Abstract
Obstructive sleep apnea hypopnea syndrome(OSAHS)is one of the most common sleep disorders in both adults and the elderly.A large number of studies in recent years have shown that OSAHS may increase the risk of cognitive impairment.This article summarizes the latest research findings on cerebrospinal fluid and plasma biomarkers associated with Alzheimer disease(AD)in patients with OSAHS,as well as how various treatment methods for OSAHS can relief the symptoms of OSAHS and alter the levels of AD biomarkers simultaneously,so as to emphasize the importance of treating OSAHS symptoms to prevent and delay the development and progression of AD.关键词
阻塞性睡眠呼吸暂停低通气综合征/阿尔茨海默病/生物标志物Key words
Obstructive sleep apnea hypopnea syndrome/Alzheimer disease/Biomarkers分类
医药卫生引用本文复制引用
葛键炜,罗本燕..阻塞性睡眠呼吸暂停低通气综合征与阿尔茨海默病生物标志物研究进展[J].中风与神经疾病杂志,2024,41(8):675-679,5.
